to improve the lives of health-minded consumers everywhere, fitlife brands' commitment to producing leading-edge proprietary nutritional supplements is just the beginning. we are dedicated to continually developing next-generation products that empower anyone, at any stage in life, to accomplish their goals. whether it’s weight loss, performance enhancement, or simply better overall health, we develop the advanced products to get them there. we step to the beat of constant innovation. while some in the industry react to developing trends, at fitlife brands, we track all leading research and follow every breakthrough in order to anticipate what each significant advancement means to our customers. when the market is ready for the next great nutritional solution in health or fitness, we’re out front, developing and bringing it to market.
Company profile
Ticker
FTLF
Exchange
Website
CEO
Dayton Judd
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BOND LABORATORIES, INC.
SEC CIK
Corporate docs
Subsidiaries
NDS Nutrition Products, Inc. • iSatori, Inc. • 1000374984 Ontario Inc. • MP Acquisition Corp. ...
FTLF stock data
Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
22 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
FitLife Brands Announces Fourth Quarter and Full-Year 2023 Results and Investor Conference Call
29 Mar 24
8-K
FitLife Brands Announces its Participation at the 36th Annual
15 Mar 24
8-K
FitLife Brands Announces Third Quarter 2023 Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
FitLife Brands Closes Acquisition of Substantially All
13 Oct 23
8-K
FitLife Brands to Acquire Substantially All of
27 Sep 23
CERT
Certification of approval for exchange listing
15 Sep 23
8-A12B
Registration of securities on exchange
14 Sep 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Dec 23 | Judd Dayton | Common Stock | Option exercise | Acquire M | No | No | 0.7 | 8,600 | 6.02 k | 437,413 |
28 Dec 23 | Judd Dayton | Stock Options Common Stock | Option exercise | Dispose M | No | No | 0.7 | 8,600 | 6.02 k | 221,400 |
15 Dec 23 | Patrick John Phillip Ryan | Common Stock | Sell | Dispose S | No | No | 24.5 | 4,000 | 98.00 k | 10,544 |
4 Oct 23 | Judd Dayton | Common Stock | Acquire X | Yes | No | 1.15 | 143,480 | 165.00 k | 2,068,128 | |
4 Oct 23 | Judd Dayton | Warrant Common Stock | Dispose X | Yes | No | 1.15 | 143,480 | 165.00 k | 0 | |
15 Aug 23 | Jakob York | Stock Options Common Stock | Grant | Acquire A | No | No | 18.15 | 2,000 | 36.30 k | 2,000 |
18 May 23 | Jakob York | Common Stock | Buy | Acquire P | No | No | 17 | 1,000 | 17.00 k | 3,484 |